CSIMarket


Terms Beginning with U
                       
                       
 U.S. Government And Federal Agency Obligations   Unemployment Rate     
 U.S. Government Securities   Unilateral Administrative Order     
 U.S. Government Sponsored Enterprise Obligations    Unit Labor Costs     
 Umbrella Coverage   United States Public Company Accounting Oversight Board     
 Unassigned Surplus   Unpaid Claims and Claims Adjustment Expenses     
 Unconfirmed complete remission CRu   Upstream     
 Underlying   Urology     
 Undeveloped reserves   US GAAP     
 Undistributed profits   USB Universal Serial Bus     
 Unearned Premium   Utility Coal     
                 
                   
 
 
       
       
 

Unconfirmed complete remission CRu

Health Care Term


Unconfirmed complete remission (CRu) is a term used in the field of oncology and refers to a state of disease in which all known signs and symptoms of cancer have disappeared after treatment, but oncologists cannot be completely sure that the cancer cells have been completely eradicated.

CRu is typically defined as the period of time after treatment when the patient is asymptomatic and no new clinical evidence of the disease can be found. However, the term "unconfirmed" is used because there may still be microscopic cancer cells present in the body that are undetectable by current diagnostic methods. Therefore, oncologists will continue to monitor the patient closely to determine if the disease returns.

CRu is an important concept in the health care industry because it represents a positive outcome in cancer treatment, but it is also a complex and important endpoint in cancer clinical trials. It is used as a measure of the effectiveness of treatment, and is often used as an endpoint in clinical trials of new cancer therapies. The ultimate goal of cancer treatment is complete remission, and CRu is an important step toward that goal.

In conclusion, unconfirmed complete remission is a term used to describe a state of disease in which all signs and symptoms of cancer have disappeared after treatment, but there may still be microscopic cancer cells present. CRu is an important measure of the effectiveness of cancer treatments and is an endpoint in clinical trials of new cancer therapies.


   
     

Unconfirmed complete remission CRu

Health Care Term


Unconfirmed complete remission (CRu) is a term used in the field of oncology and refers to a state of disease in which all known signs and symptoms of cancer have disappeared after treatment, but oncologists cannot be completely sure that the cancer cells have been completely eradicated.

CRu is typically defined as the period of time after treatment when the patient is asymptomatic and no new clinical evidence of the disease can be found. However, the term "unconfirmed" is used because there may still be microscopic cancer cells present in the body that are undetectable by current diagnostic methods. Therefore, oncologists will continue to monitor the patient closely to determine if the disease returns.

CRu is an important concept in the health care industry because it represents a positive outcome in cancer treatment, but it is also a complex and important endpoint in cancer clinical trials. It is used as a measure of the effectiveness of treatment, and is often used as an endpoint in clinical trials of new cancer therapies. The ultimate goal of cancer treatment is complete remission, and CRu is an important step toward that goal.

In conclusion, unconfirmed complete remission is a term used to describe a state of disease in which all signs and symptoms of cancer have disappeared after treatment, but there may still be microscopic cancer cells present. CRu is an important measure of the effectiveness of cancer treatments and is an endpoint in clinical trials of new cancer therapies.


Related Health Care Terms
                     
                     
 Adenocarcinoma   Analogues   Arrhythmia  
 Adenosine   ANDA Abbreviated New Drug Application   Arteriosclerosis  
 Adult Stem Cell   Angina   Atherosclerosis  
 Adverse Event   Angiogenesis   Autologous  
 Agonist   Angioplasty   Balloon Angioplasty  
 AIDS   Antagonist   Bioavailability  
 Alkylation Agent   Anti Hypertensive   Biologic Products  
 Allogeneic   Antibody   Biomarker  
 Amino Acid   Antigen   Bradycardia  
 Analgesic   API   Cancer  
               
                  next arrow
 
   


Help

About us

Advertise